173 related articles for article (PubMed ID: 32329119)
21. [Clinical characteristics of autoimmune hepatitis in 11 children].
Lu Y; Wang XH; Wang JS
Zhonghua Er Ke Za Zhi; 2010 Oct; 48(10):758-63. PubMed ID: 21176485
[TBL] [Abstract][Full Text] [Related]
22. Role of Underlying Liver Pathology in the Development of Immune-Related Hepatitis: A Case-Control Study.
Storm EM; Makrakis D; Lin GI; Talukder R; Bakaloudi DR; Shah EE; Liou IW; Hockenbery D; Grivas P; Khaki AR
Target Oncol; 2023 Jul; 18(4):601-610. PubMed ID: 37358780
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report.
Zarrabi M; Hamilton C; French SW; Federman N; Nowicki TS
Front Immunol; 2023; 14():1156746. PubMed ID: 37325672
[TBL] [Abstract][Full Text] [Related]
24. Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure.
Anastasiou OE; Dogan-Cavus B; Kucukoglu O; Baba H; Kahraman A; Gerken G; Schramm C; Canbay A
Digestion; 2018; 98(2):104-111. PubMed ID: 29698940
[TBL] [Abstract][Full Text] [Related]
25. Childhood Autoimmune Hepatitis in Bahrain: a Tertiary Center Experience.
Farid E; Isa HM; Al Nasef M; Mohamed R; Jamsheer H
Iran J Immunol; 2015 Jun; 12(2):141-8. PubMed ID: 26119196
[TBL] [Abstract][Full Text] [Related]
26. [Сlinical, immunological and morphological features in different types of autoimmune hepatitis].
Sandler YG; Saliev KG; Backih SN; Khomeriki SG; Khaymenova TY; Dorofeev AS; Sbikina ES; Vinnitskaya EV
Ter Arkh; 2020 Apr; 92(2):43-47. PubMed ID: 32598717
[TBL] [Abstract][Full Text] [Related]
27. Early Predictors of Short-Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis.
Biewenga M; Inderson A; Tushuizen ME; Crobach ASLP; van Hoek B
Liver Transpl; 2020 Dec; 26(12):1573-1581. PubMed ID: 32997870
[TBL] [Abstract][Full Text] [Related]
28. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.
Björnsson E; Talwalkar J; Treeprasertsuk S; Kamath PS; Takahashi N; Sanderson S; Neuhauser M; Lindor K
Hepatology; 2010 Jun; 51(6):2040-8. PubMed ID: 20512992
[TBL] [Abstract][Full Text] [Related]
29. Histologic surveillance after liver transplantation due to autoimmune hepatitis.
Puustinen L; Boyd S; Arkkila P; Isoniemi H; Arola J; Färkkilä M
Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235132
[TBL] [Abstract][Full Text] [Related]
30. Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis.
Fujiwara K; Fukuda Y; Seza K; Saito M; Yasui S; Nakano M; Yokosuka O; Kato N
Hepatol Int; 2018 Mar; 12(2):191-199. PubMed ID: 29450869
[TBL] [Abstract][Full Text] [Related]
31. Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure.
Mendizabal M; Marciano S; Videla MG; Anders M; Zerega A; Balderramo DC; Tisi Baña MR; Barrabino M; Gil O; Mastai R; Yantorno S; Gadano A; Silva MO
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):644-8. PubMed ID: 25923939
[TBL] [Abstract][Full Text] [Related]
32. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
[TBL] [Abstract][Full Text] [Related]
33. Clinico-laboratory study on children with auto-immune hepatitis in Upper Egypt.
Abu Faddan NH; Abdel-Baky L; Aly SA; Rashed HA
Arab J Gastroenterol; 2011 Dec; 12(4):178-83. PubMed ID: 22305497
[TBL] [Abstract][Full Text] [Related]
34. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
Kerkar N; Yanni G
J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
[TBL] [Abstract][Full Text] [Related]
35. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients.
Kogan J; Safadi R; Ashur Y; Shouval D; Ilan Y
J Clin Gastroenterol; 2002 Jul; 35(1):75-81. PubMed ID: 12080231
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced Hypophysitis.
Quandt Z; Kim S; Villanueva-Meyer J; Coupe C; Young A; Kang JH; Yazdany J; Schmajuk G; Rush S; Ziv E; Perdigoto AL; Herold K; Lechner MG; Su MA; Tyrrell JB; Bluestone J; Anderson M; Masharani U
J Endocr Soc; 2023 Feb; 7(4):bvad012. PubMed ID: 36860908
[TBL] [Abstract][Full Text] [Related]
37. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
[TBL] [Abstract][Full Text] [Related]
39. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A
Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094
[TBL] [Abstract][Full Text] [Related]
40. Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.
Choi J; Choi GH; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Kim KM
Liver Int; 2019 May; 39(5):985-994. PubMed ID: 30821090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
